LAPTM5 and lung carcinoma: Enrichment analysis confirmed that genes highly associated with B cells or DC1 strongly correlated with immune activation in lung cancer patients, with LAPTM5 being highly related to DC1, suggesting its role in predicting the efficacy of immune checkpoint blockade (ICB) [18].